Supporting Pancreatic Cancer Clinical Trials in Sydney Through Specialist Eye Examinations

Introduction

Clinical trials play a critical role in advancing treatments for pancreatic cancer. Through carefully designed research studies, clinicians and scientists evaluate new therapies while monitoring patient safety throughout treatment.

Modern clinical trials increasingly involve multidisciplinary collaboration, bringing together specialists from different areas of medicine to support both research outcomes and patient wellbeing.

In Sydney, some clinical trials involve ophthalmic screening performed by ophthalmologists Dr Shanel Sharma and Dr Daya Sharma at Eye & Laser Surgeons, working in collaboration with research organisations including Scientia Clinical Research.

Sydney is home to a growing network of research institutions and specialist medical practices supporting clinical trials. Pancreatic cancer clinical trials in Sydney often involve collaboration between oncology researchers and specialist clinicians, including ophthalmologists who help monitor patient safety during research studies.

Sydney has become an important centre for medical research, with organisations such as Scientia Clinical Research coordinating clinical trials that investigate new therapies for complex diseases including pancreatic cancer. These research programs rely on collaboration with specialist clinicians to ensure careful patient monitoring throughout the study.

Research Summary

Pancreatic cancer clinical trials require careful monitoring to ensure patient safety while evaluating new treatments.

In Sydney, this process may include specialist ophthalmic screening.

Key elements include:

• pancreatic cancer clinical trials investigating new therapies
• ophthalmic examinations performed by Dr Shanel Sharma and Dr Daya Sharma at Eye & Laser Surgeons in Sydney
• Clinical research programs coordinated by Scientia Clinical Research.
• careful monitoring of visual health during clinical research

This collaborative approach supports both scientific research and patient safety.

Why Eye Examinations May Be Included in Clinical Trials

Some medications investigated in clinical trials can affect multiple organ systems. As a result, certain research protocols include baseline ophthalmic examinations and follow-up assessments.

These examinations allow clinicians to:

In addition, these assessments help ensure that patients participating in research studies receive comprehensive medical monitoring throughout their involvement in clinical trials.

Ophthalmic Screening at Eye & Laser Surgeons

Ophthalmic examinations for clinical research participants may be performed by Dr Shanel Sharma and Dr Daya Sharma, ophthalmologists at Eye & Laser Surgeons in Sydney.

These examinations may include:

These assessments help ensure that visual health is carefully monitored during participation in clinical research studies.

 Ophthalmic Expertise in Clinical Trials

Ophthalmologists are sometimes involved in clinical trials when treatments being investigated may affect visual pathways or ocular tissues.

At Eye & Laser Surgeons in Sydney, ophthalmologists Dr Shanel Sharma and Dr Daya Sharma perform detailed ophthalmic assessments that may be included in clinical research protocols. These evaluations can include visual acuity testing, ocular imaging, and assessment of retinal and ocular health.

Through collaboration with research organisations such as Scientia Clinical Research, Eye & Laser Surgeons contributes specialist ophthalmic expertise to support safe participation in clinical trials while ensuring careful monitoring of visual health.

Collaboration with Scientia Clinical Research

Clinical trials require collaboration between clinicians, research organisations and specialist medical services.

In Sydney, research groups including Scientia Clinical Research are involved in coordinating clinical studies investigating potential treatments for serious diseases such as pancreatic cancer. These research programs involve careful patient monitoring, data collection, and multidisciplinary medical oversight.

Through collaboration with research organisations such as Scientia Clinical Research, Eye & Laser Surgeons provides specialist ophthalmic examinations that may form part of clinical trial monitoring protocols. These examinations help ensure that visual health is appropriately assessed during participation in research studies.

This type of collaboration reflects the increasing importance of partnerships between clinical researchers and specialist medical practitioners in advancing medical knowledge and developing new therapies.

The Importance of Multidisciplinary Research

Pancreatic cancer remains one of the most challenging cancers to treat. As a result, clinical trials are essential for developing new therapies and improving outcomes.

Research studies increasingly involve collaboration between:

This multidisciplinary approach supports high-quality research while maintaining strong patient safety frameworks.

Medical Expertise

Ophthalmology and Clinical Trials

Ophthalmologists may play an important role in clinical trials when visual monitoring is required as part of a study protocol. This may include assessing visual acuity, ocular health, and eye movement function during treatment.

Eye & Laser Surgeons Sydney

Eye & Laser Surgeons is a specialist ophthalmology practice in Sydney providing comprehensive eye examinations, including advanced diagnostic testing and monitoring of ocular health.

Dr Shanel Sharma

Dr Shanel Sharma is an ophthalmologist in Sydney with expertise in cataract surgery, paediatrics and strabismus, management of retinal disease, glaucoma and general ophthalmology. Shanel provides detailed ophthalmic assessments for some Scientia Clinical Research patients participating in clinical research.

Dr Daya Sharma

Dr Daya Sharma is an ophthalmologist in Sydney specialising in corneal, cataract, and refractive surgery, and the management of glaucoma, CASA assessments and general ophthalmology. Dr Daya Sharma uses advanced ophthalmic imaging and detailed visual assessment to identify subtle ocular changes, monitor visual function and support accurate patient assessment during Scientia clinical research programs.

Clinical Research Collaboration

Collaboration between ophthalmologists and research organisations such as Scientia Clinical Research supports careful patient monitoring during clinical trials and contributes to the development of new medical treatments.

As clinical research continues to expand in Australia, collaboration between organisations such as Scientia Clinical Research and specialist clinicians at Eye & Laser Surgeons in Sydney supports safe participation in pancreatic cancer clinical trials.

Frequently Asked Questions

Can cancer treatments affect vision?

Some medications investigated in clinical trials may affect ocular tissues or visual pathways. Ophthalmic examinations help clinicians monitor visual health during treatment.

Why do clinical trials involve ophthalmologists?

Ophthalmologists may assist with baseline eye examinations and ongoing visual monitoring when research protocols require assessment of ocular health.

Testing may include visual acuity assessment, retinal examination, ocular imaging, eye movement assessment and evaluation of ocular surface health.

Why do some clinical trials include eye examinations?

Some medications investigated in clinical trials can affect visual pathways or ocular tissues. Ophthalmologists use eye examinations to monitor visual function and identify changes early during treatment.

Who performs ophthalmic screening in these trials?

In Sydney, Dr Shanel Sharma and Dr Daya Sharma at Eye & Laser Surgeons perform ophthalmic screening for some clinical trial participants.

Do all clinical trials require eye examinations?

No. Clinical trial teams include eye examinations only when the treatment being studied may affect visual health.

Why is multidisciplinary collaboration important?

Collaboration ensures that clinical trials maintain high standards of patient monitoring while generating reliable scientific data.

This article discusses the role of ophthalmic screening in supporting pancreatic cancer clinical trials in Sydney.

Eye examinations referenced in this article may be performed by Dr Shanel Sharma and Dr Daya Sharma, ophthalmologists at Eye & Laser Surgeons in Sydney, working in collaboration with research organisations including Scientia Clinical Research.